• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Exits

Ergon et al. sell Indo to PE-backed Rodenstock

  • Harriet Matthews
  • Harriet Matthews
  • 19 May 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Ergon Capital, Sherpa Capital and Oquendo Capital have sold Spain-based ophthalmic lenses manufacturer Indo to Rodenstock, a Germany-based optical lenses and glasses frames producer backed by Apax Partners and Mubadala Capital.

A source familiar with the situation told Unquote that a structured auction process was not necessary for the deal, given the strategic fit between the two businesses.

A second source familiar said that the deal values Indo in the EUR 150m-200m range.

Indo

  • DEAL:

    Trade sale; portfolio management

  • VALUE:

    EUR 150m-200m (est)

  • LOCATION:

    Sant Cugat del Vallès

  • SECTOR:

    Medical equipment

  • FOUNDED:

    1937

  • STAFF:

    440

  • VENDOR:

    Ergon Capital, Sherpa Capital, Oquendo Capital

Spanish publication Expansion reported earlier in May 2022 that Ergon was in advanced negotiations with Rodenstock to sell Indo, with the company expected to be valued at more than EUR 160m. The report stated that Ergon held a 70% stake in Indo at the time of the sale.

Ergon acquired Indo in June 2018 in an SBO from Sherpa Capital. The deal saw Sherpa retain a minority stake in the business, with debt provided by direct lender Oquendo Capital. Ergon deployed equity via Ergon Capital Partners III, which held a final close in 2010 on EUR 500m, with an additional EUR 150m raised for the fund in 2016. The fund typically deploys equity tickets of EUR 25m-75m, investing in European mid-market businesses.

Sherpa Capital originally acquired Indo in 2013 in the form of a carve-out of the production unit of Grupo Indo, which was declared bankrupt in 2010. The GP deployed equity via its EUR 30m, 2010-vintage debut fund, which was dedicated to distressed companies based in Spain. The investment was later held in the GP's Special Situations II fund, which held a final close in May 2014 on EUR 100m.

A third source familiar told Unquote that Sherpa Capital held a stake of 20% at the time of the exit.

During Ergon’s investment period, the company expanded its client base and invested in its production plants and new product launches, according to a statement from Indo’s selling shareholders.

Apax and Mubadala acquired Rodenstock from Compass Partners in a EUR 1.5bn SBO in March 2021.

Rodenstock said in a statement that the deal is expected to complete in Q3 2022 and is subject to competition authority approval. The statement added that Rodenstock expects to see significant growth in Indo’s operations in Morocco, where the market is expected to grow at 10% CAGR between 2022 and 2027.

Houlihan Lokey, Rodenstock, Apax Partners and Sherpa Capital declined to comment. Ergon Capital had not responded to requests for comment at the time of publication.

Company
Founded in 1937 and headquartered in Sant Cugat del Vallès, Indo manufactures ophthalmic lenses and distributes medical equipment for the eye care sector. The company employs 440 staff, versus 350 at the time of its acquisition by Ergon. It operates in Spain, Morocco, Portugal and France, with manufacturing plants in Barcelona and Tangier.

People
Ergon Capital – Pablo Álvarez Couso (managing director); Emanuele Lembo (senior partner).
Indo – Enric Florensa (CEO).
Rodenstock – Anders Hedegaard (CEO); Marcus Desimoni (CFO).
Apax Partners – Steven Dyson (partner, co-head of healthcare); Arthur Brothag (partner).

Advisers
Vendor – Houlihan Lokey (corporate finance).
Acquirer – PwC (financial due diligence); WTS (tax); BCG (commercial due diligence); Uría Menendez (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Exits
  • Portfolio management
  • Southern Europe
  • Healthcare
  • Build-up
  • Trade sale
  • Spain
  • Ergon Capital Partners
  • Apax Partners

More on Exits

Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
Lender taking the keys from a sponsor
Ares Management handed keys to two-thirds of UK sponsor’s portfolio

Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported

  • Financing
  • 30 August 2023
Luggage and airport services
Actera Group explores strategic options for Celebi Ground Handling

Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal

  • Exits
  • 30 August 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013